ACE Report Cover
AAOS 2024: Use of An Arthroplasty-Specific Mobile Application For Patient-Reported Outcomes
Language
Download
Cite
+ Favorites
Language
Download
Cite
+ Favorites
AceReport Image
ARTHROPLASTY
AAOS 2024: Use of An Arthroplasty-Specific Mobile Application For Patient-Reported Outcomes .

Completion of patient-reported outcome measures improved with use of an arthroplasty-specific mobile application; results from a randomized controlled trial

1285 patients undergoing either hip or knee arthroplasty were randomized to either the mobile app (n=384) or control (n=451) groups. In this secondary analysis, outcomes of interest included compliance rates, health-related quality of life (HRQOL), Knee Injury and Osteoarthritis Outcome Score for Joint Replacement (KOOS JR), and Hip Injury and Osteoarthritis Outcome Score for Joint Replacement (HOOS JR). Comprehensive Joint Replacement (CJR) submission rules were also applied to compare compliance between the two groups. Mobile app users showed significantly higher compliance in completing Patient-Reported Outcome Measures (PROMs) preoperatively and at every time point postoperatively. The strongest predictors of compliance were the use of the app, younger age, and higher preoperative PROMs scores. Patients over 65 years old using the app also showed higher compliance than younger patients using paper methods.

Unlock the Full ACE Report

You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now

Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics

Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics

Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions

Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics

Or upgrade today and gain access to all OrthoEvidence
content for as little as $1.99 per week.
0 of 4 monthly FREE articles unlocked
You've reached your limit of 4 free articles views this month

Access to OrthoEvidence for as little as $1.99 per week.

Stay connected with latest evidence. Cancel at any time.
  • Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
  • Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
  • Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Upgrade
Welcome Back!
Forgot Password?
Start your FREE trial today!

Account will be affiliated with


OR
Forgot Password?

OR
Please check your email

If an account exists with the provided email address, a password reset email will be sent to you. If you don't see an email, please check your spam or junk folder.

For further assistance, contact our support team.

Translate ACE Report

OrthoEvidence utilizes a third-party translation service to make content accessible in multiple languages. Please note that while every effort is made to ensure accuracy, translations may not always be perfect.

Cite this ACE Report

OrthoEvidence. AAOS 2024: Use of An Arthroplasty-Specific Mobile Application For Patient-Reported Outcomes. ACE Report. 2024;306(2):23. Available from: https://myorthoevidence.com/AceReport/Show/aaos-2024-use-of-an-arthroplasty-specific-mobile-application-for-patient-reported-outcomes

Copy Citation
Please login to enable this feature

To access this feature, you must be logged into an active OrthoEvidence account. Please log in or create a FREE trial account.

Premium Member Feature

To access this feature, you must be logged into a premium OrthoEvidence account.

Share this ACE Report